WallStreetZenWallStreetZen

NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CANF

Based on 2 analysts offering 12 month price targets for Can Fite Biopharma Ltd

Min Forecast
$2.50-27.11%
Avg Forecast
$3.25-5.25%
Max Forecast
$4.00+16.62%

Should I buy or sell CANF stock?

Based on 2 analysts offering ratings for Can Fite Biopharma Ltd.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CANF's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CANF as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.

CANF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-11-04

1 of 1

CANF vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CANF$3.43$3.25-5.25%Strong Buy
CLDI$0.31N/AN/A
BRTX$0.25N/AN/A
ASBP$0.88N/AN/A
HCWB$0.88N/AN/A
View Top Biotech Stocks

Can Fite Biopharma Stock Forecast FAQ

Is Can Fite Biopharma Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: CANF) stock is to Strong Buy CANF stock.

Out of 2 analysts, 1 (50%) are recommending CANF as a Strong Buy, 1 (50%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

What is CANF's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CANF price target, the average CANF price target is $3.25, with the highest CANF stock price forecast at $4.00 and the lowest CANF stock price forecast at $2.50.

On average, Wall Street analysts predict that Can Fite Biopharma's share price could fall to $3.25 by Dec 17, 2026. The average Can Fite Biopharma stock price prediction forecasts a potential downside of 5.25% from the current CANF share price of $3.43.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.